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According to the oxidative-inﬂammatory theory of aging, there is a link between the function, the oxidative-inﬂammatory stress
state of immune cells, and longevity. However, it is unknown which immune cell parameters can predict lifespan and if there
would be any changes in this prediction, depending on the age of the subject. Therefore, a longitudinal study in mice was
performed analysing immune function (chemotaxis of macrophages and lymphocytes, phagocytosis of macrophages, natural
killer (NK) activity, and lymphoproliferation capacity), antioxidant (catalase (CAT), glutathione peroxidase (GPx), and
glutathione reductase (GR) activities as well as reduced glutathione (GSH) concentrations), oxidant (oxidized glutathione
(GSSG), superoxide anion, and malondialdehyde (MDA) concentrations), and inﬂammation-related markers (basal release of
IL-1β, IL-6, TNF-α, and IL-10) in peritoneal leukocytes from mice at the adult, mature, old, very old, and long-lived ages
(40, 56, 72, 96, and 120 ± 4 weeks of age, respectively). The results reveal that some of the investigated parameters are
determinants of longevity at the adult age (lymphoproliferative capacity, lymphocyte chemotaxis, macrophage chemotaxis
and phagocytosis, GPx activity, and GSH, MDA, IL-6, TNF-α, and IL-10 concentrations), and therefore, they could be
proposed as markers of the rate of aging. However, other parameters are predictive of extreme longevity only at the very old
age (NK activity, CAT and GR activities, and IL-6 and IL-1β concentrations), and as such, they could reﬂect some of the
adaptive mechanisms underlying the achievement of high longevity. Nevertheless, although preliminary, the results of the
present study provide a new perspective on the use of function, redox, and inﬂammatory parameters in immune cells as
prognostic tools in aging research and represent a novel benchmark for future work aimed at prediction of lifespan.
1. Introduction
Nowadays, increasing average life expectancy is turning the
focus of gerontologists from trying to increase lifespan to
experiencing healthy aging by prolonging the so-called
“healthspan” [1]. It has been predicted that in 2050, 22% of
the world population will be over 60 years old. Thus, many
countries are facing an increased prevalence of age-related
diseases and increasing healthcare costs given that the rapid
rise in older people is accompanied by an increase in the
number of subject with chronic age-related diseases, such as
heart disease, lung disease, stroke, cancer, and diabetes [2].
However, some individuals live more than a century without
ever suﬀering from the chronic diseases that aﬄict most
humans much earlier in their lives. Therefore, focus should
be placed on the study of those successful phenotypes to
assist in the understanding of aging. Thus, centenarians have
been shown to retain independence and capability as well
as cognition at higher levels for longer than the general
population, together with postponed mortality [2–5].
Therefore, their study might help to achieve an extended
healthy lifespan for the wider population.
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Several theories have been proposed to explain the
aging process. The oxidative-inﬂammatory theory of aging
[6] links the age-related increase in oxidative stress [7, 8]
with the chronic low-grade inﬂammation, the so-called
“inﬂamm-aging” [9], through the interplay of the immune
system. It is known that the age-related increase in oxidative
stress impairs the correct functioning of cells. Given that
oxidation and inﬂammation are interlinked processes, the
increase in oxidative stress in immune cells results in an
increased release of proinﬂammatory mediators, giving as a
result the age-related establishment of a chronic oxidative
and inﬂammatory stress [6]. According to this theory, a
relationship has been found between the oxidative and
inﬂammatory states of immune cells, their functional capac-
ity, and the lifespan of a subject [6]. In this regard, it has been
demonstrated that centenarians have immune cell function
and redox parameters similar to those in adults, despite their
advanced age [10, 11]. However, if they maintain this optimal
functionality during their whole lifespan or they undergo
some remodelling of these parameters during aging is
unknown. Therefore, a deep understanding of these subjects
would require their follow-up throughout the aging process
to shed light into which changes or adaptations are the
“successful ones.” Since a longitudinal study is impossible
to carry out in human subjects throughout the whole aging
process, mice, which have a mean longevity of 2 years, were
used for this work. In addition, peritoneal leukocytes were
chosen as a sample of study given that they can be extracted
without killing the mouse and in the absence of anaesthesia.
This fact allowed the monitoring of mice from the adult age
until the natural death of the animals.
Thus, a longitudinal study was performed analysing
several functions (macrophage chemotaxis and phagocyto-
sis, natural killer activity, lymphocyte chemotaxis, and
lymphoproliferation capacity), redox parameters (catalase,
glutathione peroxidase, and glutathione reductase activities,
reduced and oxidized glutathione, and superoxide anion
and malondialdehyde concentrations), and inﬂammatory
mediators (basal release of IL-6, IL-1β, TNF-α, and IL-10)
in peritoneal leukocytes throughout the aging process of
mice. This approach allowed us to address three important
questions: (i) which markers are the most important predic-
tors of remaining longevity in adult or middle life? (ii) Are
the same parameters predictive of successful aging at very
advanced age? (iii) Which changes or adaptations an individ-
ual experiences throughout his/her lifetime that allow the
attainment of extreme longevity?
2. Material and Methods
2.1. Experimental Animals and Extraction of Peritoneal
Leukocytes. 40 female outbred ICR/CD1 exreproductive mice
(Mus musculus) were acquired from Janvier Labs (Germany)
when they were 32 ± 4 weeks old. The collection of perito-
neal suspensions was performed at the adult (40 ± 4 weeks;
n = 38), mature (56 ± 4 weeks; n = 25), old (72 ± 4 weeks;
n = 15), very old (96 ± 4 weeks; n = 11), and long-lived
(120 ± 4 weeks; n = 3) ages. Mice were further divided at each
age point into adult mice (survivors, n = 22; nonsurvivors,
n = 13; and long-lived, n = 3); mature mice (survivors,
n = 12; nonsurvivors, n = 10; and long-lived, n = 3); old mice
(survivors, n = 8; nonsurvivors, n = 4; and long-lived, n = 3);
and very old mice (survivors, n = 3; nonsurvivors, n = 8).
All the animals had a natural death, whereas when no
weight loss (<20%), moribund state, or tumor formation
was detected, the cause of death was not further investigated.
Leukocytes from peritoneal suspensions were identiﬁed by
their morphology (macrophages or lymphocytes) and quan-
tiﬁed (number of cells/mL) in Neubauer chambers. The
measurement of markers was performed using unfractio-
nated peritoneal leukocytes to better reproduce the in vivo
situation. The peritoneal suspensions were adjusted to a
speciﬁc number of macrophages, lymphocytes, or total leu-
kocytes, depending on the parameter analysed as described
in the corresponding section.
2.2. Analysis of Immune Function Parameters
2.2.1. Chemotaxis. Cell suspensions were adjusted to 0 5 × 106
cells (macrophages or lymphocytes)/mL in Hank’s medium
and placed into a Boyden chamber. The number of cells
that migrated towards formyl-Met-Leu-Phe was counted
and expressed as the Chemotaxis Index, as previously
described [11].
2.2.2. Phagocytosis.Cell suspensions were adjusted to 0 5 × 106
macrophages/mL in Hank’s medium and placed into
migration inhibition factor (MIF) plates for 30 min. After
washing, latex beads were added into the plates and the
number of latex beads ingested by 100 macrophages
was counted and expressed as the Phagocytic Index, as
previously described [11].
2.2.3. Natural Killer (NK) Cytotoxicity. Cell suspensions were
adjusted to 106 total cells/mL in RPMI 1640 medium and
placed into 96-well plates. Murine YAC-1 lymphoma cells
were added into wells, and NK activity was assessed by
quantifying released lactate dehydrogenase into the medium
(Cytotox 96 TM, Promega, Germany). The results were
expressed as the percentage of tumor cells killed (% lysis),
as previously described [11].
2.2.4. Lymphoproliferative Capacity. Cell suspensions were
adjusted to 0 5 × 106 lymphocytes/mL in RPMI 1640
medium supplemented with fetal bovine serum (FBS) and
placed into 96-well plates. The mitogen concanavalin A
(Con A) or complete medium was added into wells and incu-
bated for 48 h. Then, 3H-thymidine was also added and
incubated for 24 h. 3H-Thymidine uptake was quantiﬁed
in a beta counter both in basal and stimulated conditions,
and results were expressed as lymphoproliferation capacity
(%), 100% being the counts per minute (cpm) in basal
conditions, as previously described [11].
2.3. Determination of Redox Parameters
2.3.1. Catalase (Cat) Activity. Cell suspensions were adjusted
to 106 total cells/mL in Hank’s medium and centrifuged, and
cell pellets were resuspended in oxygen-free phosphate buﬀer
50 mM. Then, they were sonicated and supernatants were
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used for the enzymatic reaction together with 14 mM H2O2
as substrate. Decomposition of H2O2 was measured at
240 nm as previously described [12]. The results were
expressed as units (U) of catalase activity/mg protein.
2.3.2. Glutathione Peroxidase (GPx) Activity. Cell suspen-
sions were adjusted to 106 total cells/mL in Hank’s medium
and centrifuged, and cell pellets were resuspended in
oxygen-free phosphate buﬀer 50 mM. Then, they were
sonicated and supernatants were used for the enzymatic
reaction together with cumene hydroperoxide as a substrate
(cumene-OOH) as previously described [12]. Oxidation of
NADPH was measured at 340 nm. The results were
expressed as units (U) of GPx activity/mg protein.
2.3.3. Glutathione Reductase (GR) Activity. Cell suspensions
were adjusted to 106 total cells/mL in Hank’s medium and
centrifuged, and the cell pellets were resuspended in
oxygen-free phosphate buﬀer 50 mM and EDTA 6.3 mM.
Then, they were sonicated and supernatants were used for
the enzymatic reaction together with oxidized glutathione
(GSSG) 80 mM as substrate, as previously described [12].
Oxidation of NADPH was measured at 340 nm. The results
were expressed as units (U) of GR activity/mg protein.
2.3.4. Glutathione Concentration. Cell suspensions were
adjusted to 106 total cells/mL in Hank’s medium and centri-
fuged, and cell pellets were resuspended in phosphate buﬀer
50 mM and EDTA 0.1 M, pH 8. Then, they were sonicated
and supernatants were used for the quantiﬁcation of both
reduced (GSH) and oxidized (GSSG) glutathione by
the reaction capacity that GSSG and GSH have with
o-phthalaldehyde (OPT) at pH 12 and pH 8, respectively,
resulting in the formation of a ﬂuorescent compound, as pre-
viously described [12]. Fluorescence was measured at 350 nm
excitation and 420 nm emission. Results were expressed as
nmol of GSSG and GSH per milligram of protein. Moreover,
the GSSG/GSH ratio was calculated for each sample.
2.3.5. Intracellular Superoxide Anion Concentration. Cell
suspensions were adjusted to 106 macrophages/mL in
Hank’s medium and mixed with nitroblue tetrazolium
(NBT) (1 mg/mL). After 60 min incubation, the reaction
was stopped with HCl 0.5 M; samples were centrifuged
and supernatants discarded. Intracellular reduced NBT was
extracted with dioxan and absorbance was measured at
525 nm, as previously described [12]. Results were expressed
as nmol superoxide anion/106 macrophages.
2.3.6. Malondialdehyde (MDA) Concentration. Determina-
tion ofMDA concentration was evaluated using the commer-
cial kit “Lipid Peroxidation (MDA) Assay Kit” (BioVision,
CA, USA). Cell suspensions were adjusted to 106 total
cells/mL in Hank’s medium and centrifuged, and cell pellets
were resuspended in MDA lysis buﬀer. Then, they were
sonicated and supernatants were incubated with thiobarbi-
turic acid (TBA) for 60 min in a water bath. Then, samples
were centrifuged and supernatants collected and dispensed
into 96-well plates for spectrophotometric measurement at
532 nm. Results were expressed as nmol MDA/mg protein.
2.4. Determination of Inﬂammatory Parameters
2.4.1. Cytokine Measurement. After incubation of peritoneal
immune cells for 48 hours in the absence of any mitogen
(basal conditions), supernatants were collected. The basal
release of IL-1β, IL-6, TNF-α, and IL-10 was measured
simultaneously in these supernatants by multiplex lumino-
metry (Beadlyte mouse multiplex cytokine detection system,
MHYSTOMAG-70K, Upstate, Millipore).
2.5. Statistical Analysis. Diﬀerences between groups of the
same age were studied using Student’s t-test for independent
samples. Age-related diﬀerences in the group of long-lived
mice were studied using Student’s t-test for paired samples.
Two-sided P < 0 05 was considered the minimum level of
signiﬁcance. In order to investigate the potential role of the
parameters studied as predictors of lifespan, Pearson’s
correlation coeﬃcients were calculated for each of the param-
eters studied at each age and the respective lifespan that each
individual mouse achieved.
3. Results
Several immune function, redox, and inﬂammatory parame-
ters were assessed in peritoneal leukocytes from female
mice, throughout a longitudinal study, starting at the age
of 40 weeks until the natural death of the animals. Each
mouse was monitored individually along its aging process.
At each age analysed, the results are shown classifying
mice into three groups: those that lived until the next
age point studied, those that died before the next age
point, and the animals that reached extreme longevity.
Regarding immune function parameters (Figure 1), mice
of the group that survived until the next age point show, in
general, a better immune functionality than those that die.
However, diﬀerences exist depending on the parameter and
the age point investigated. Accordingly, mice that reach
extreme longevity also show better immune functions, in
general, compared to those that die and in some cases even
better than those that live to the next age point studied.
When focusing on the age-related changes that those mice
that reach extreme longevity undergo, it was found that they
experience a decrease in almost all immune functions when
they are old followed by a subsequent increase at the very
old age, showing optimal immune function values when they
are long-lived.
With respect to antioxidant parameters (Figures 2(a)–
2(d)), there are almost no diﬀerences between those mice that
survived until the next age point and those that died. How-
ever, the group of mice that reach extreme longevity shows
a higher antioxidant capacity, in general, compared to those
that die at most of the ages studied. This group of mice that
reach high longevity experience an age-related decrease in
GSH concentration compared to when they were adults,
but they undergo a large increase in GPx and GR activities
when they are close to reaching extreme longevity.
In relation to oxidant parameters (Figures 2(e)–2(h)), the
group of mice that survive to the next age and those that
become long-lived show lower GSSG/GSH ratios and MDA
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Figure 1: Immune function parameters analysed in peritoneal leukocytes from mice throughout a longitudinal study: (a) macrophage
chemotaxis; (b) macrophage phagocytosis; (c) natural killer activity; (d) lymphocyte chemotaxis; (e) lymphoproliferation. A: adult mice
(40 weeks old; n = 38); M: mature mice (56 weeks old; n = 25); O: old mice (72 weeks old; n = 18); VO: very old mice (96 weeks old; n = 11);
LG: long-lived mice (120 weeks old; n = 3). ∗P < 0 05; ∗∗P < 0 01; ∗∗∗P < 0 001 with respect to the group of mice that die before the next
age point (Student’s t-test for independent samples). a: P < 0 05, aa: P < 0 01 with respect to adult mice that reach extreme
longevity; b: P < 0 05, bb: P < 0 01 with respect to mature mice that reach extreme longevity; c: P < 0 05 with respect to old mice
that reach extreme longevity (Student’s t-test for paired samples).
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Figure 2: Redox parameters analysed in peritoneal leukocytes from mice throughout a longitudinal study: (a) catalase (Cat) activity;
(b) glutathione peroxidase (GPx) activity; (c) glutathione reductase (GR) activities; (d) reduced glutathione (GSH) concentration;
(e) superoxide anion concentration; (f) oxidized glutathione (GSSG) concentration; (g) GSSG/GSH ratio; (h) MDA concentration.
A: adult mice (40 weeks old; n = 38); M: mature mice (56 weeks old; n = 25); O: old mice (72 weeks old; n = 18); VO: very old mice (96 weeks
old; n = 11); LG: long-lived mice (120 weeks old; n = 3). ∗P < 0 05; ∗∗P < 0 01; ∗∗∗P < 0 001 with respect to the group of mice that die before
the next age point (Student’s t-test for independent samples). a: P < 0 05, aa: P < 0 01 with respect to adult mice that reach high longevity;
b: P < 0 05, bb: P < 0 01 with respect to mature mice that reach high longevity; c: P < 0 05 with respect to old mice that reach high
longevity; d: P < 0 05, dd: P < 0 01 with respect to very old mice that reach high longevity (Student’s t-test for paired samples).
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concentrations than those that die. Long-lived mice experi-
ence an increase in almost all oxidant parameters when they
are old and very old, followed by a subsequent decrease, and
thus showing optimal levels when they are long-lived.
Regarding inﬂammatory mediators (Figure 3), both the
groups of mice that survive to the next age and those that
reach high longevity show, at most of the ages studied, lower
basal release of proinﬂammatory cytokines and higher
release of the anti-inﬂammatory cytokine IL-10, compared
to those that die. Those mice that become long-lived
experience a gradual increase in IL-6, IL-1β, and TNF-α
when they age, but they lessen TNF-α basal release when they
are long-lived. In the same way, they experience a slight
decrease in IL-10 basal release when they age, followed by a
large increase when they are long-lived.
Due to the observed heterogeneity of values for a given
parameter among mice from the same age group and given
that the lifespan of each mouse was monitored individually,
it was possible to investigate the relationship between the
values of a given parameter of each mouse at a certain age
and its ﬁnal achieved lifespan.
With respect to immune function parameters (Figure 4),
a positive correlation was found between the chemotaxis
capacity of macrophages and lifespan at the adult, mature,
old, and very old ages (P < 0 01; P < 0 01; P < 0 05; and
P < 0 01, respectively) and between the phagocytic ability
of macrophages and achieved lifespan at the adult and very
old ages (P < 0 01; P < 0 05, respectively). In addition, posi-
tive correlations were also found between the NK activity
and remaining lifespan at the very old age (P < 0 05),
between the chemotaxis capacity of lymphocytes and life-
span at the adult age (P < 0 01), and between the ability
of lymphocytes to proliferate in response to Con A and
achieved lifespan at the adult and mature ages (P < 0 01;
P < 0 05, respectively).
Regarding redox parameters (Figure 5), there are positive
correlations between Cat and GR activities and lifespan at the
very old age (P < 0 05; P < 0 01, respectively) and between
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Figure 3: Basal release of cytokines in peritoneal leukocytes from mice throughout a longitudinal study: (a) IL-6 concentration (pg/mL);
(b) IL-1β concentration (pg/mL); (c) TNF-α concentration (pg/mL); (d) IL-10 concentration (pg/mL). A: adult mice (40 weeks old;
n = 38); M: mature mice (56 weeks old; n = 25); O: old mice (72 weeks old; n = 18); VO: very old mice (96 weeks old; n = 11); LG: long-
lived mice (120 weeks old; n = 3). ∗P < 0 05; ∗∗P < 0 01; ∗∗∗P < 0 001 with respect to the group of mice that die before the next age point
(Student’s t-test for independent samples). a: P < 0 05, aa: P < 0 01 with respect to adult mice that reach high longevity; b: P < 0 05 with
respect to mature mice that reach high longevity; c: P < 0 05 with respect to old mice that reach high longevity (Student’s t-test for
paired samples).
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GPx activity and lifespan at the adult, mature, and very old
ages (P < 0 05; P < 0 05; and P < 0 01, respectively). In
addition, a positive correlation was found between GSH
concentration and lifespan at the adult and old ages
(P < 0 01), whereas a negative correlation was found between
MDA concentration and lifespan at the adult and mature
ages (P < 0 01).
With respect to the inﬂammatory mediators (Figure 6),
there is a negative correlation between basal release of IL-6
and lifespan at the adult age (P < 0 01) and a positive
correlation between basal release of IL-6 and lifespan at the
very old age (P < 0 05). Likewise, a negative correlation was
found between IL-1β and lifespan at the mature age
(P < 0 05) whereas a positive correlation was found between
IL-1β and lifespan at the very old age (P < 0 05). For TNF-α,
there is a negative correlation between its basal release and
achieved lifespan at the adult, mature, and very old ages
(P < 0 05; P < 0 01; and P < 0 05, respectively), whereas
for IL-10 there is a positive correlation with lifespan at
the adult, old, and very old ages (P < 0 01).
4. Discussion
Biomarkers of aging are deﬁned by their quality of predicting
life expectancy, but given that life expectancy data for many
individuals are diﬃcult to collect, most of the studies estab-
lish “biomarkers of age” instead of biomarkers of aging.
The “biomarkers of age” concept is simply based on cross-
sectional trends of features as a function of time. According
to [13], “the regular and progressive changes over time
per se do not constitute aging unless they produce some
deleterious outcome.” Thus, using longitudinal evidence,
biomarkers of age can be validated as biomarkers of aging if
high or low values are associated with deleterious or beneﬁ-
cial eﬀects [14, 15]. The present longitudinal study shows
that several function, redox, and inﬂammatory parameters
of immune cells are strongly related to lifespan. Neverthe-
less, the most outstanding contribution is that this relation-
ship with lifespan is diﬀerent for each parameter depending
on the age of the subject. Thus, our results show that certain
parameters, such as the ability to proliferate and migrate
towards a stimulus of lymphocytes, the capacity to migrate
and ingest foreign particles of macrophages, the GPx acti-
vity, concentration of GSH and MDA as well as the basal
release of IL-6, TNF-α and IL-10, strongly correlate with
the ﬁnal achieved lifespan of each individual mouse at the
adult age. The early power of these parameters in forecasting
lifespan highlights their essential role for the maintenance of
health throughout aging, and therefore, they could be used
as biomarkers of the rate of aging, i.e., of biological age. In
addition, some of these parameters, such as macrophage
chemotaxis and phagocytosis, GPx activity and basal release
of TNF-α and IL-10, are also predictive of lifespan at very
old age, and thus, they could be investigated in old animals
in order to discriminate which will reach extreme longevity.
The fact that macrophage function relates to lifespan across
lifetime supports the hypothesis of phagocytes being the
main cells responsible for the chronic oxidative and inﬂam-
matory stress associated with immunosenescence and there-
fore responsible for the rate of aging of a subject [6, 16, 17].
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In addition, the strong relation to lifespan of GPx activity
during aging could be due to its ability to disarm hydrogen
peroxide, limiting its harmful eﬀects and therefore playing a
critical role against oxidative stress establishment. It could
also be related to its ability to inhibit degradation of the
inhibitory subunit α of nuclear factor-kappa b (NF-kB)
[18], and thus, decreasing NF-kB activation, this enzyme
could counteract inﬂammatory stress. In fact, in a previous
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Figure 6: Pearson’s correlation coeﬃcient for each cytokine basal release and lifespan at each age. Adult mice: 40 weeks old. Mature mice:
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study, it was demonstrated that those mice which reach
high longevity had a low level of basal NF-kB activation
[19]. In accordance with that, it was found in the present
study that the lower the release of the proinﬂammatory
TNF-α and the higher the release of the anti-inﬂammatory
IL-10 during aging, the greater the chance of achieving
higher longevity. These results agree with a previous study
in which a low basal release of TNF-α and a high release
of IL-10 were reported in extremely long-lived mice [20]
and with another one in which the IL-10/TNF-α ratio
was proposed as a marker of longevity in mice [21].
Furthermore, another striking ﬁnding of our study is
that there are some parameters which were not associated
with longevity at the adult age, but they become strong
discriminant parameters for reaching extreme longevity
at the very old age. This is the case for the natural killer
(NK) cytotoxic activity and CAT and GR activities as well
as the basal release of IL-6 and IL-1β. This fact probably
indicates that these markers reﬂect some underlying me-
chanisms, which are needed to reach high longevity. With
respect to NK cytotoxicity and antioxidant CAT and GR
activities, there seems to be a “biological purpose.” The
higher the NK cytotoxic activity against tumor cells and
the higher the decomposition of ROS at very old age,
the higher the possibility of becoming long-lived. How-
ever, what is the “biological purpose” of an increased IL-6
and IL-1β release at very old age if it exacerbates the chronic
inﬂammatory stress? One potential explanation could be
that the age-related increase in proinﬂammatory cytokines
is delayed in long-lived mice, this being the reason why
they show a high release of both cytokines at very old
age. Another possibility could be that these cytokines
might be playing an essential role regulating and orches-
trating other cells given that only those mice which are
able to increase their basal release at the very old age
are the ones that later on reach high longevity. Ac-
cordingly, recent studies have unravelled a new role of
IL-6 in mediating the reprogramming of cells associated
with senescence [22], which could reverse the age-
associated silencing of important antioxidant and anti-
inﬂammatory genes.
In addition, another intriguing discovery of the study is
that certain parameters can be prolongevity or antilongevity
depending on the age window studied. In the present study,
the NK cytotoxicity and the CAT and GR activities as well as
the basal release of IL-6 and IL-1β were negatively associated
with longevity at the adult age. However, at the very old age,
their signiﬁcance totally changes, the higher these para-
meters the higher the lifespan achieved. Thus, these para-
meters seem to exhibit a reverse antagonistic pleiotropy. In
fact, there are some other examples of markers whose roles
(early antilongevity, late prolongevity) also change during
aging such as the systolic blood pressure [23–26] or body
mass index [27, 28]. Therefore, these results underscore
the necessity to take into account the age of the indivi-
dual when investigating the predictive power of a given
parameter towards longevity. Moreover, they also have
important practical applications, as several strategies
designed to promote longevity may be useful, useless, or
harmful depending on the age at which they are carried
out, as previously suggested [14]. In agreement with the
results of the present study, overexpression of mitochon-
drial CAT in young mice was found to be detrimental,
whereas its overexpression in old mice had a positive
eﬀect [29]. Thus, it seems that ROS exhibit conventional
antagonistic pleiotropy explaining why stronger antioxi-
dant mechanisms have not evolved under natural selec-
tion of young animals in nature.
Finally, our study is the ﬁrst one to show the age-
associated changes, regarding function, redox and inﬂam-
matory parameters in immune cells, which a long-lived
individual experiences from adulthood to death. It has been
proposed that long-lived individuals have a slower or dece-
lerated aging rate [30], maintaining optimal cell functioning
through aging. Strikingly, the results from our study reveal
that long-lived subjects do not maintain optimal functioning,
redox, and inﬂammatory state of their leukocytes throughout
their aging. In fact, they also experience an age-associated
impairment when they are old, although slighter than the
one suﬀered by those who do not reach these advanced ages.
However, they are able to adapt and rearrange these para-
meters at the very old age, showing optimal levels when they
are long-lived. It seems that those individuals which show
more biological plasticity or adaptive homeostasis [31] by
restoring or even increasing cytotoxic NK activity and
macrophage functions, antioxidant enzyme activities (CAT,
GPx, and GR activities), and basal release of cytokines
(IL-6, IL-1β, IL-10, and TNF-α) at the very old age achieve
higher longevity. The most important limitation of the
work is the small sample size of mice that reached extreme
longevity, and therefore, the results of the present study
should be validated using a larger number of mice. In
addition, the observed relationships between these param-
eters and longevity should also be investigated in males,
given that female mice, in addition to having a longer life-
span than male mice, also display a diﬀerent immunity
and oxidative and inﬂammatory states, among other cha-
racteristics [32]. Therefore, it seems plausible that those
markers that are predictive of longevity in female mice
could be diﬀerent to those in males. Nevertheless, although
preliminary, the results of the present study provide a new
perspective on the use of function, redox, and inﬂamma-
tory parameters of immune cells as prognostic tools in
aging research and represent a novel benchmark for future
work aimed at prediction of lifespan. Moreover, given that
the function and oxidative stress of immune cells have
been shown to follow a similar pattern in humans and
mice [11, 12], strategies that are aimed at boosting the
NK cytotoxicity, macrophage functions, and antioxidant
enzyme activities as well as at controlling basal cytokine
release in elderly individuals could help in achieving
healthy aging for the general population.
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